Synageva BioPharma Corp (NASDAQ:GEVA)

104.05
Delayed Data
As of 1:06pm ET
 +2.81 / +2.78%
Today’s Change
60.19
Today|||52-Week Range
122.88
+12.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues1.6M2.3M1.3M1.2M
 
 
 
 
 
Depreciation And Amortization1.4M1.7M1.3M--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses36.7M50.9M48.1M58.3M
 
 
 
 
 
Other Operating Expenses0.000.000.00244.0K
 
 
Research And Development26.9M38.3M33.6M40.6M
 
 
 
 
 
Total Operating Expenses38.1M52.7M49.4M58.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.5M-50.3M-48.0M-57.3M
 
 
 
 
 
Pre-Tax Equity Earnings0.00---400.0K--
 
 
Other Expenses-5.0K-9.0K88.0K88.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.4M-50.2M-48.3M-57.2M
 
 
 
 
 
Income Taxes-18.0K-16.0K-16.0K-490.0K
 
 
 
 
 
Net Income-36.4M-50.2M-48.3M-57.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.3M33.1M33.2M33.3M
 
 
 
 
 
Shares To Calculate EPS Diluted31.3M33.1M33.2M33.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.16-$1.52-$1.46-$1.73
 
 
 
 
 
EPS Diluted-$1.16-$1.52-$1.46-$1.73
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account